Zoetis Inc. (LON:0M3Q)

Market Cap	42.67B
Revenue (ttm)	6.99B
Net Income (ttm)	1.97B
Shares Out	n/a
EPS (ttm)	4.42
PE Ratio	21.64
Forward PE	19.44
Dividend	1.53 (1.19%)
Ex-Dividend Date	Oct 31, 2025

Volume	9,712
Average Volume	8,323
Open	128.40
Previous Close	127.48
Day's Range	127.80 - 132.43
52-Week Range	115.69 - 181.21
Beta	0.96
RSI	49.92
Earnings Date	Nov 4, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1950
• Employees: 13,800
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M3Q

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD